RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

RO.CH

332.4

+0.42%↑

NOVN.CH

123.18

+0.31%↑

LONN.CH

513.6

0%↓

SDZ.CH

63.8

-0.09%↓

STMN.CH

83.56

+0.14%↑

Home・Aandelen Lijst・Bachem Holding AG

Bachem Holding AG

Gesloten

SectorGezondheidszorg

66.05 -1.34

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

66.35

Belangrijke statistieken
By Trading Economics
Inkomsten	49M 99M
Verkoop	69M 382M
K/W Sectorgemiddelde	31.97 56.063
Dividendrendement	1.42
Winstmarge	25.83
Werknemers	2,130
EBITDA	35M 107M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+24.83% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.42% 2.45%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	672M 4.7B
Vorige openingsprijs	67.39
Vorige sluitingsprijs	66.05

Nieuwssentiment

By Acuity

43%

57%

153 / 349 Rangschikking in Healthcare

Bachem Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 apr 2026, 17:11 UTC

Belangrijke Marktbewegers

Belangrijke Nieuwsgebeurtenissen

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2 apr 2026, 17:10 UTC

Belangrijke Nieuwsgebeurtenissen

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3 apr 2026, 00:00 UTC

Belangrijke Nieuwsgebeurtenissen

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2 apr 2026, 23:47 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2 apr 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2 apr 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2 apr 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2 apr 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2 apr 2026, 21:01 UTC

Belangrijke Nieuwsgebeurtenissen

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2 apr 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Starbucks and Boyu Capital Finalize China JV

2 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

2 apr 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

2 apr 2026, 20:41 UTC

Winsten

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 apr 2026, 20:32 UTC

Marktinformatie

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2 apr 2026, 20:30 UTC

Acquisities, Fusies, Overnames

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 apr 2026, 20:09 UTC

Marktinformatie

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2 apr 2026, 20:01 UTC

Acquisities, Fusies, Overnames

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 apr 2026, 19:46 UTC

Marktinformatie

Is Oil the New GameStop? -- Market Talk

2 apr 2026, 19:35 UTC

Marktinformatie

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2 apr 2026, 19:29 UTC

Acquisities, Fusies, Overnames

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 apr 2026, 19:24 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2 apr 2026, 19:20 UTC

Marktinformatie

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2 apr 2026, 19:01 UTC

Acquisities, Fusies, Overnames

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2 apr 2026, 19:00 UTC

Acquisities, Fusies, Overnames

Union Pacific: Agreement Reached With American Train Dispatchers Association

2 apr 2026, 18:24 UTC

Acquisities, Fusies, Overnames

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2 apr 2026, 17:44 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2 apr 2026, 17:32 UTC

Belangrijke Nieuwsgebeurtenissen

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2 apr 2026, 17:26 UTC

Winsten

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 apr 2026, 17:17 UTC

Marktinformatie

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2 apr 2026, 17:09 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Peer Vergelijking

Prijswijziging

Bachem Holding AG Prognose

Koersdoel

By TipRanks

24.83% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 83.2 CHF 24.83%

Hoogste 110 CHF

Laagste 60 CHF

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bachem Holding AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Bachem Holding AG - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

153 / 349 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.